Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Genet ; 81(3): 249-56, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21231929

ABSTRACT

Hereditary coproporphyria (HCP) is an autosomal dominantly inherited hepatic porphyria, caused by a mutation in the coproporphyrinogen oxidase (CPOX) gene. The genetic defect leads to a partial defect of CPOX, the sixth enzyme involved in haem biosynthesis. Affected individuals can develop acute life-threatening attacks of neurovisceral symptoms and/or more rarely cutaneous symptoms such as skin fragility and blistering. The identification of the genetic defect in HCP families is of crucial importance to detect the carrier status which allows counselling to prevent possible triggering factors, e.g. certain drugs, alcohol, or fasting. In a total of nine Swedish HCP families, routine gene sequence analysis had identified a causative mutation in only five. In the present study, using an in-house developed synthetic probe set for multiplex ligation-dependent probe amplification (MLPA) analysis, we detected a deletion of the fifth exon in the CPOX gene in the remaining four families. The deletion is 3381 bp in size and has originated by an Alu-mediated mechanism. This finding emphasizes the usefulness of MLPA analysis as a complement to gene sequencing for comprehensive genetic diagnostics in HCP patients.


Subject(s)
Coproporphyria, Hereditary/genetics , Coproporphyrinogen Oxidase/genetics , Sequence Deletion , Coproporphyria, Hereditary/diagnosis , Exons , Female , Genetic Carrier Screening , Genetic Counseling , Haplotypes , Humans , Male , Pedigree , Polymorphism, Single Nucleotide , Sweden/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...